Metabolites of the aquatic pollutant diclofenac in fish bile

Environmental Science and Technology

Volumn 44, Issue 19, 2010, Pages 7213-7219

  Kallio, Jenny Maria ^a   Lahti, Marja ^b   Oikari, Aimo ^b   Kronberg, Leif ^a  

^a ÅBO AKADEMI UNIVERSITY   (Finland)

^b UNIVERSITY OF JYVÄSKYLÄ   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-INFLAMMATORY DRUGS; BIOCONCENTRATION FACTOR; DICLOFENAC; FISH BILE; FRAGMENTATION PATTERNS; GLUCURONIDES; INTRAPERITONEALLY; ION TRAP MASS ANALYZERS; MASS DETERMINATION; ONCORHYNCHUS MYKISS; PRECURSOR IONS; RAINBOW TROUT; TIME-OF-FLIGHT MASS ANALYZER; WASTEWATER TREATMENT PLANTS;

BIOMOLECULES; BODY FLUIDS; ETHERS; HYDROXYLATION; METABOLITES; WASTEWATER; WASTEWATER TREATMENT; WATER POLLUTION; WATER TREATMENT PLANTS;

METABOLISM;

4' HYDROXYDICLOFENAC; 4',5 DIHYDROXYDICLOFENAC; 5 HYDROXYDICLOFENAC; ACYL GLUCURONIDE; DICLOFENAC; ETHER GLUCURONIDE; GLUCURONIDE; ION; UNCLASSIFIED DRUG;

BIOACCUMULATION; CONCENTRATION (COMPOSITION); DRUG; IDENTIFICATION METHOD; METABOLISM; METABOLITE; ORGANIC POLLUTANT; SALMONID; WASTE FACILITY; WASTEWATER; WATER TREATMENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BILE; BIOACCUMULATION; CONCENTRATION (PARAMETERS); DRUG EXPOSURE; FRAGMENTATION REACTION; HYDROXYLATION; ION TRAP MASS SPECTROMETRY; METABOLISM; METABOLITE; NONHUMAN; PRECURSOR; RAINBOW TROUT; TIME OF FLIGHT MASS SPECTROMETRY; WASTE WATER MANAGEMENT; WATER POLLUTANT; WATER POLLUTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BILE; CHROMATOGRAPHY, LIQUID; DICLOFENAC; FISHES; MASS SPECTROMETRY; WATER POLLUTANTS, CHEMICAL;

ONCORHYNCHUS MYKISS;

EID: 77957373792     PISSN: 0013936X     EISSN: 15205851     Source Type: Journal    
DOI: 10.1021/es903402c     Document Type: Article

References (25)

1. Halling-Sørensen, B.; Nors Nielsen, S.; Lanzky, P. F.; Ingerslev, F.; Holten Lützhøft, H. C.; Jørgensen, S. E. Occurrence, fate and effects of pharmaceutical substances in the environment - A review Chemosphere 1998, 36, 357-393
2. Daughton, C. G.; Ternes, T. A. Pharmaceuticals and personal care products in the environment: agents of subtle change Environ. Health Perspect. Suppl. 1999, 107, 907-938
3. Lindqvist, N.; Tuhkanen, T.; Kronberg, L. Occurrence of acidic pharmaceuticals in raw and treated sewages and in receiving waters Water Res. 2005, 39, 2219-2228
4. Vieno, N. M.; Tuhkanen, T.; Kronberg, L. Seasonal variation in the occurrence of pharmaceuticals in effluents from a sewage treatment plant and in the recipient water Environ. Sci. Technol. 2005, 39, 8220-8226
5. MacLeod, S. L.; McClure, E. L.; Wong, C. S. Laboratory calibration and field development of the polar organic chemical integrative sampler for pharmaceuticals and personal care products in wastewater and surface water Environ. Toxicol. Chem. 2007, 26, 2517-2529
6. Perez, S.; Barcelo, D. First evidence for occurrence of hydroxylated human metabolites of diclofenac and aceclofenac in wastewater using QqLIT-MS and QqTOF-MS Anal. Chem. 2008, 80, 8135-8145
7. Stuelten, D.; Zuehlke, S.; Lamshoeft, M.; Spiteller, M. Occurrence of diclofenac and selected metabolites in sewage effluents Sci. Total Environ. 2008, 405, 310-316
8. Ferrari, B.; Paxeus, N.; Lo Giudice, R.; Pollio, A.; Garric, J. Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac Ecotoxicol. Environ. Saf. 2003, 55, 359-370
9. Haap, T.; Triebskorn, R.; Köhler, H. Acute effects of diclofenac and DMSO to Daphnia magna: Immobilisation and hsp70-induction Chemosphere 2008, 73, 353-359
10. Schwaiger, J.; Ferling, H.; Mallow, U.; Wintermayr, H.; Negele, R. D. Toxic effects of the non-steroidal anti-inflammatory drug diclofenac: Part I: histopathological alterations and bioaccumulation in rainbow trout Aquat. Toxicol. 2004, 68, 141-150 (Pubitemid 38622488)
11. Triebskorn, R.; Casper, H.; Heyd, A.; Eikemper, R.; Köhler, H.; Schwaiger, J. Toxic effects of the non-steroidal anti-inflammatory drug diclofenac: Part II. Cytological effects in liver, kidney, gills and intestine of rainbow trout (Oncorhynchus mykiss) Aquat. Toxicol. 2004, 68, 151-166
12. Triebskorn, R.; Casper, H.; Scheil, V.; Schwaiger, J. Ultrastructural effects of pharmaceuticals (carbamazepine, clofibric acid, metoprolol, diclofenac) in rainbow trout (Oncorhynchus mykiss) and common carp (Cyprinus carpio) Anal. Bioanal. Chem. 2007, 387, 1405-1416
13. Hoeger, B.; Köllner, B.; Dietrich, D. R.; Hitzfeld, B. Water-borne diclofenac affects kidney and gill integrity and selected immune parameters in brown trout (Salmo trutta f. fario) Aquat. Toxicol. 2005, 75, 53-64
14. Brown, J. N.; Paxéus, N.; Förlin, L.; Larsson, D. G. J. Variations in bioconcentration of human pharmaceuticals from sewage effluents into fish blood plasma Environ. Toxicol. Pharmacol. 2007, 24, 267-274
15. Sawchuk, R. J.; Maloney, J. A.; Cartier, L. L.; Rackley, R. J.; Chan, K. K. H.; Lau, H. S. L. Analysis of diclofenac and four of its metabolites in human urine by HPLC Pharm. Res. 1995, 12, 756-762
16. Bort, R.; Macé, K.; Boobis, A.; Gómez-Lechón, M.; Pfeifer, A.; Castell, J. Hepatic metabolism of diclofenac: role of human CYP in the minor oxidative pathways Biochem. Pharmacol. 1999, 58, 787-796
17. Kumar, S.; Samuel, K.; Subramanian, R.; Braun, M. P.; Stearns, R. A.; Chiu, S. L.; Evans, D. C.; Baillie, T. A. Extrapolation of diclofenac clearance from in vitro microsomal metabolism data: role of acyl glucuronidation and sequential oxidative metabolism of the acyl glucuronide J. Pharmacol. Exp. Ther. 2002, 303, 969-978
18. Kenny, J. R.; Maggs, J. L.; Meng, X.; Sinnott, D.; Clarke, S. E.; Park, B. K.; Stachulski, A. V. Syntheses and characterization of the acyl glucuronide and hydroxy metabolites of diclofenac J. Med. Chem. 2004, 47, 2816-2825
19. Corcoran, O.; Nicholson, J. K.; Lenz, E. M.; Abou-Shakra, F.; Castro-Perez, J.; Sage, A. B.; Wilson, I. D. Directly coupled liquid chromatography with inductively coupled plasma mass spectrometry and orthogonal acceleration time-of-flight mass spectrometry for the identification of drug metabolites in urine: Application to diclofenac using chlorine and sulfur detection Rapid Commun. Mass Spectrom. 2000, 14, 2377-2384
20. EMEA. Guideline on Environmental Impact Assessment for Veterinary Medicinal Products in Support of the VICH Guidelines GL6 and GL38; EMEA/CVMP/ERA/418282/2005-Consultation: London, 2006; pp 1 - 59.
21. Aresta, A.; Carbonara, T.; Palmisano, F.; Zambonin, C. G. Profiling urinary metabolites of naproxen by liquid chromatography-electrospray mass spectrometry J. Pharm. Biomed. Anal. 2006, 41, 1312-1316
22. Levsen, K.; Schiebel, H.; Behnke, B.; Dötzer, R.; Dreher, W.; Elend, M.; Thiele, H. Structure elucidation of phase II metabolites by tandem mass spectrometry: An overview J. Chromatogr., A 2005, 1067, 55-72
23. 1H NMR used for determination of the elution order of S-naproxen glucuronide isomers in two isocratic reversed-phase LC-systems J. Pharm. Biomed. Anal. 2001, 24, 477-485
24. Ternes, T. A. Occurrence of drugs in German sewage treatment plants and rivers Water Res. 1998, 32, 3245-3260
25. Scheurell, M.; Franke, S.; Shah, R. M.; Hühnerfuss, H. Occurrence of diclofenac and its metabolites in surface water and effluent samples from Karachi, Pakistan Chemosphere 2009, 77, 870-876